Full View

Efficacy of gefitinib for non‐adenocarcinoma non‐small‐cell lung cancer patients harboring epidermal growth factor receptor mutations: A pooled analysis of …

T Shukuya, T Takahashi, R Kaira, A Ono… - Cancer …, 2011 - Wiley Online Library
The efficacy of gefitinib for patients with non‐adenocarcinoma non‐small‐cell lung cancer
(NSCLC) harboring epidermal growth factor receptor (EGFR) mutations is unclear, because …
被引用次数：171 相关文章

Efficacy of gefitinib for non‐adenocarcinoma non‐small‐cell lung cancer patients harboring epidermal growth factor receptor mutations: A pooled analysis of …

T Shukuya, T Takahashi, R Kaira, A Ono, Y Nakamura… - Cancer Science, 2011 - cir.nii.ac.jp
抄録< jats: p> The efficacy of gefitinib for patients with non‐adenocarcinoma non‐small‐cell
lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) mutations is …
[HTML] nih.gov

[HTML][HTML] Efficacy of gefitinib for non‐adenocarcinoma non‐small‐cell lung cancer patients harboring epidermal growth factor receptor mutations: A pooled analysis of …

T Shukuya, T Takahashi, R Kaira, A Ono… - Cancer …, 2011 - ncbi.nlm.nih.gov
The efficacy of gefitinib for patients with non‐adenocarcinoma non‐small‐cell lung cancer
(NSCLC) harboring epidermal growth factor receptor (EGFR) mutations is unclear, because …

[引用][C] Efficacy of gefitinib for non-adenocarcinoma non-small-cell lung cancer patients harboring epidermal growth factor receptor mutations: A pooled analysis of …

T SHUKUYA, T TAKAHASHI, M ENDO… - Cancer …, 2011 - pascal-francis.inist.fr
Efficacy of gefitinib for non-adenocarcinoma non-small-cell lung cancer patients harboring
epidermal growth factor receptor mutations: A pooled analysis of published reports CNRS Inist …

Efficacy of gefitinib for non‐adenocarcinoma non‐small‐cell lung cancer patients harboring epidermal growth factor receptor mutations: A pooled analysis of …

T Shukuya, T Takahashi, R Kaira, A Ono, Y Nakamura… - Cancer Science, 2011 - infona.pl
The efficacy of gefitinib for patients with non‐adenocarcinoma non‐small‐cell lung cancer
(NSCLC) harboring epidermal growth factor receptor (EGFR) mutations is unclear, because …

Efficacy of gefitinib for non-adenocarcinoma non-small-cell lung cancer patients harboring epidermal growth factor receptor mutations: a pooled analysis of published …

T Shukuya, T Takahashi, R Kaira, A Ono… - Cancer …, 2011 - europepmc.org
The efficacy of gefitinib for patients with non-adenocarcinoma non-small-cell lung cancer
(NSCLC) harboring epidermal growth factor receptor (EGFR) mutations is unclear, because …

Efficacy of gefitinib for non-adenocarcinoma non-small-cell lung cancer patients harboring epidermal growth factor receptor mutations: a pooled analysis of published …

T Shukuya, T Takahashi, R Kaira, A Ono… - Cancer …, 2011 - pubmed.ncbi.nlm.nih.gov
The efficacy of gefitinib for patients with non-adenocarcinoma non-small-cell lung cancer
(NSCLC) harboring epidermal growth factor receptor (EGFR) mutations is unclear, because …

[引用][C] Efficacy of gefitinib for non-adenocarcinoma non-small-cell lung cancer patients harboring epidermal growth factor receptor mutations: A pooled analysis of …

S Takehito, T Toshiaki, K Rieko, ONO Akira, N Yukiko… - Cancer science, 2011 - cir.nii.ac.jp
Efficacy of gefitinib for non-adenocarcinoma non-small-cell lung cancer patients harboring
epidermal growth factor receptor mutations : A pooled analysis of published reports | CiNii …

[引用][C] Efficacy of gefitinib for non-adenocarcinoma non-small-cell lung cancer patients harboring epidermal growth factor receptor mutations: A pooled analysis of …

T SHUKUYA, T TAKAHASHI, R KAIRA, A ONO… - Cancer science, 2011 - Blackwell